Her postpartum symptoms wouldn't go away. A brain tumor was to blame.

Lisa Fasone's first pregnancy went smoothly. Then a rare health condition put her dreams of a second child on hold.
Read the original report
Opens CBS News in a new tab

Lisa Fasone's first pregnancy went smoothly. Then a rare health condition put her dreams of a second child on hold.
Opens CBS News in a new tab
An 18‑week referral‑to‑treatment target has been backed by England's former national cancer director.
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.